collaborate1.jpg

We are unique in that we have both an investment team and an R&D and operations team. Rather than recruit new teams for each drug candidate that we license from universities, a small group of proven scientists and executives manages all such Orange Grove Bio programs.

 

These individuals also collaborate with portfolio companies in which we invest to ensure that preclinical development is managed efficiently at those entities.